72 related articles for article (PubMed ID: 16858075)
1. Serum free light chains: an alternative to the urine Bence Jones proteins screening test for monoclonal gammopathies.
Hill PG; Forsyth JM; Rai B; Mayne S
Clin Chem; 2006 Sep; 52(9):1743-8. PubMed ID: 16858075
[TBL] [Abstract][Full Text] [Related]
2. Differences in kappa to lambda (kappa:lambda) ratios of serum and urinary free light chains.
Abe M; Goto T; Kosaka M; Wolfenbarger D; Weiss DT; Solomon A
Clin Exp Immunol; 1998 Feb; 111(2):457-62. PubMed ID: 9486419
[TBL] [Abstract][Full Text] [Related]
3. Kappa Free Light Chain Drift Prompts the Need for a New Upper Limit of Normal Free Light Chain Ratio to Avoid an Epidemic of Kappa Light Chain Monoclonal Gammopathy of Undermined Significance.
Rozenova K; Willrich M; Snyder M; Dasari S; Kourelis T; Rajkumar SV; Kumar S; Dispenzieri A; Murray DL
J Appl Lab Med; 2023 Jul; 8(4):742-750. PubMed ID: 37232112
[TBL] [Abstract][Full Text] [Related]
4. Circulating antibody free light chains and risk of posttransplant lymphoproliferative disorder.
Engels EA; Preiksaitis J; Zingone A; Landgren O
Am J Transplant; 2012 May; 12(5):1268-74. PubMed ID: 22300426
[TBL] [Abstract][Full Text] [Related]
5. Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance.
Rajkumar SV; Kyle RA; Therneau TM; Melton LJ; Bradwell AR; Clark RJ; Larson DR; Plevak MF; Dispenzieri A; Katzmann JA
Blood; 2005 Aug; 106(3):812-7. PubMed ID: 15855274
[TBL] [Abstract][Full Text] [Related]
6. Detection and Characterization of Paraproteinemia in Canine Chronic B-cell Lymphocytic Leukemia Using Routine and Free Light Chain Immunofixation.
Harris RA; Gary EB; Rout ED; Avery AC; Moore AR
Vet Clin Pathol; 2022 Dec; 51(4):551-559. PubMed ID: 35883213
[TBL] [Abstract][Full Text] [Related]
7. Urine Immunofixation Electrophoresis for Diagnosis of Monoclonal Gammopathy: Evaluation of Methods for Urine Concentration.
Ye Mon M; Ufondu O; Mortley S; Bollag RJ; Singh G
J Appl Lab Med; 2024 Mar; 9(2):350-356. PubMed ID: 38180079
[TBL] [Abstract][Full Text] [Related]
8. Oligoclonal Pattern/Abnormal Protein Bands in Post-Treatment Plasma Cell Myeloma Patients: Implications for Protein Electrophoresis and Serum Free Light Chain Assay Results.
Singh G
J Clin Med Res; 2017 Aug; 9(8):671-679. PubMed ID: 28725315
[TBL] [Abstract][Full Text] [Related]
9. Effects of aerobic and resistance exercise for 9 months on serum free light chains in type 2 diabetes.
Kim Y; Campbell JP; Johannsen NM; Church TS; Cho E; Heaney J; Spielmann G
Front Physiol; 2024; 15():1328470. PubMed ID: 38725572
[No Abstract] [Full Text] [Related]
10. Immunoglobulin repertoire sequencing and de novo sequencing - Powerful tools for identifying free light chains from patients with light chain cast nephropathy.
Wang X; Liu Y; Yong ZH; Yu XJ; Zhou FD; Zhao MH
Int Immunopharmacol; 2024 Jun; 135():112302. PubMed ID: 38772298
[TBL] [Abstract][Full Text] [Related]
11. Can serum free light chains replace urine electrophoresis in the detection of monoclonal gammopathies?
Beetham R; Wassell J; Wallage MJ; Whiteway AJ; James JA
Ann Clin Biochem; 2007 Nov; 44(Pt 6):516-22. PubMed ID: 17961305
[TBL] [Abstract][Full Text] [Related]
12. Screening panels for detection of monoclonal gammopathies.
Katzmann JA; Kyle RA; Benson J; Larson DR; Snyder MR; Lust JA; Rajkumar SV; Dispenzieri A
Clin Chem; 2009 Aug; 55(8):1517-22. PubMed ID: 19520758
[TBL] [Abstract][Full Text] [Related]
13. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders.
Dispenzieri A; Kyle R; Merlini G; Miguel JS; Ludwig H; Hajek R; Palumbo A; Jagannath S; Blade J; Lonial S; Dimopoulos M; Comenzo R; Einsele H; Barlogie B; Anderson K; Gertz M; Harousseau JL; Attal M; Tosi P; Sonneveld P; Boccadoro M; Morgan G; Richardson P; Sezer O; Mateos MV; Cavo M; Joshua D; Turesson I; Chen W; Shimizu K; Powles R; Rajkumar SV; Durie BG;
Leukemia; 2009 Feb; 23(2):215-24. PubMed ID: 19020545
[TBL] [Abstract][Full Text] [Related]
14. Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays.
Katzmann JA; Dispenzieri A; Kyle RA; Snyder MR; Plevak MF; Larson DR; Abraham RS; Lust JA; Melton LJ; Rajkumar SV
Mayo Clin Proc; 2006 Dec; 81(12):1575-8. PubMed ID: 17165636
[TBL] [Abstract][Full Text] [Related]
15. Serum-free light chain test utilisation at a South African academic laboratory and comparison with serum protein electrophoresis results.
Banderker RB; Fazel FB; Zemlin AE; Khine AA; Jalavu TP
Afr J Lab Med; 2023; 12(1):2201. PubMed ID: 38058849
[TBL] [Abstract][Full Text] [Related]
16. A Cohort Study of Free Light Chain Ratio in Combination with Serum Protein Electrophoresis as a First-Line Test in General Practice.
Sandfeld-Paulsen B; Aggerholm-Pedersen N; Samson MH; Møller HJ
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740597
[TBL] [Abstract][Full Text] [Related]
17. Light chain myeloma and detection of free light chains in serum and urine of dogs and cats.
Harris RA; Miller M; Donaghy D; Ashton L; Langston C; Shockey T; Moore AR
J Vet Intern Med; 2021 Mar; 35(2):1031-1040. PubMed ID: 33634914
[TBL] [Abstract][Full Text] [Related]
18. A Study on Free Light Chain Assay and Serum Immunofixation Electrophoresis for the Diagnosis of Monoclonal Gammopathies.
Kuriakose E; Narayanan Unni Cheppayil S; Kuzhikandathil Narayanan S; Vasudevan A
Indian J Clin Biochem; 2019 Jan; 34(1):76-81. PubMed ID: 30728676
[TBL] [Abstract][Full Text] [Related]
19. Multiple Myeloma Masquerading as Ovarian Carcinosarcoma Metastases: A Case Report and Review of the Approach to Multiple Myeloma Screening and Diagnosis.
Stuver R; Petersen A; Guerrero-Garcia TA; Matulonis U; Richardson P; Singh P
Case Rep Hematol; 2018; 2018():3029650. PubMed ID: 30345126
[TBL] [Abstract][Full Text] [Related]
20. Bence Jones proteinuria in smoldering multiple myeloma as a predictor marker of progression to symptomatic multiple myeloma.
González-Calle V; Dávila J; Escalante F; de Coca AG; Aguilera C; López R; Bárez A; Alonso JM; Hernández R; Hernández JM; de la Fuente P; Puig N; Ocio EM; Gutiérrez NC; García-Sanz R; Mateos MV
Leukemia; 2016 Oct; 30(10):2026-2031. PubMed ID: 27133826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
